These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 34364170)

  • 1. Angiogenesis pattern and H3.3 histone mutation in aggressive and non-aggressive central giant cell lesions.
    de Oliveira Filho SA; Martins AFL; Mosconi C; de Paula HM; Mendonça EF
    Arch Oral Biol; 2021 Oct; 130():105218. PubMed ID: 34364170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Tumor Angiogenesis by Expression of CD 105 in Ameloblastoma, Odontogenic Keratocyst and Central Giant Cell Lesion.
    Ali K; Zeb Khan S; Sultana N; Alghamdi O; Muhammad S; Mokeem SA; Ali S; Abduljabbar T; Vohra F
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3373-3379. PubMed ID: 33247698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Endoglin (CD105) expression in pediatric rhabdomyosarcoma.
    Di Paolo V; Russo I; Boldrini R; Ravà L; Pezzullo M; Benedetti MC; Galardi A; Colletti M; Rota R; Orlando D; Crocoli A; Peinado H; Milano GM; Di Giannatale A
    BMC Cancer; 2018 Jan; 18(1):31. PubMed ID: 29304781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FASN expression, angiogenesis and lymphangiogenesis in central and peripheral giant cell lesions.
    Falci SG; Mesquita AT; Andrade BA; Miranda JL; Leon JE; Almeida OP; Santos CR
    J Appl Oral Sci; 2014 Apr; 22(2):131-7. PubMed ID: 24676584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Study of Correlation between Angiogenesis Markers (CD31) and Ki67 Marker with Behavior of Aggressive and Nonaggressive Central Giant Cell Granuloma with Immunohistochemistry Technique.
    Razavi SM; Yahyaabadi R
    Asian Pac J Cancer Prev; 2018 Aug; 19(8):2279-2283. PubMed ID: 30139237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Giant cell lesions of the jaws: does the level of vascularity and angiogenesis correlate with behavior?
    Peacock ZS; Jordan RC; Schmidt BL
    J Oral Maxillofac Surg; 2012 Aug; 70(8):1860-6. PubMed ID: 22104131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mononuclear cell phagocytosis in giant cell lesions of the jaws.
    Sousa-Neto SS; Pereira GB; Mendonça EF; Martins AFL
    Stomatologija; 2023; 25(4):91-96. PubMed ID: 39133129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of microvessel density determined by an anti-CD105/endoglin monoclonal antibody in astrocytic tumors: comparison with an anti-CD31 monoclonal antibody.
    Yao Y; Kubota T; Takeuchi H; Sato K
    Neuropathology; 2005 Sep; 25(3):201-6. PubMed ID: 16193836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of mast cells and microvessels density in reactive lesions of oral cavity: A comparative immunohistochemical study.
    Ferreira SV; Xavier FC; Freitas Mda C; Nunes FD; Gurgel CA; Cangussu MC; Martins MD; Freitas VS; Dos Santos JN
    Pathol Res Pract; 2016 Sep; 212(9):761-6. PubMed ID: 27493102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoglin is a better marker than CD31 in evaluation of angiogenesis in glioblastoma.
    Behrem S; Zarkovic K; Eskinja N; Jonjic N
    Croat Med J; 2005 Jun; 46(3):417-22. PubMed ID: 15861521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neovascularity as a prognostic marker in renal cell carcinoma.
    Bauman TM; Huang W; Lee MH; Abel EJ
    Hum Pathol; 2016 Nov; 57():98-105. PubMed ID: 27436827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
    Basilio-de-Oliveira RP; Pannain VL
    World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of VEGF, CD105, and CD31 in the Prognosis of Colorectal Cancer Cases.
    Mohamed SY; Mohammed HL; Ibrahim HM; Mohamed EM; Salah M
    J Gastrointest Cancer; 2019 Mar; 50(1):23-34. PubMed ID: 29110224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoexpression of MMP-9, VEGF, and vWF in central and peripheral giant cell lesions of the jaws.
    Matos FR; Nonaka CF; Miguel MC; Galvão HC; de Souza LB; Freitas Rde A
    J Oral Pathol Med; 2011 Apr; 40(4):338-44. PubMed ID: 21198871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endoglin (CD105) is a useful marker for evaluating microvessel density and predicting prognosis in esophageal squamous cell carcinoma.
    Sakurai T; Okumura H; Matsumoto M; Uchikado Y; Owaki T; Kita Y; Setoyama T; Omoto I; Kijima Y; Ishigami S; Natsugoe S
    Anticancer Res; 2014 Jul; 34(7):3431-8. PubMed ID: 24982351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucocorticoids, calcitonin, and osteocalcin cannot differentiate between aggressive and nonaggressive central giant cell lesions of the jaws.
    Martins AF; Souza PO; Rege IC; Morais MO; Mendonça EF
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Sep; 120(3):386-95. PubMed ID: 26188731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic value of endoglin (CD105) expression in ovarian carcinoma.
    Taskiran C; Erdem O; Onan A; Arisoy O; Acar A; Vural C; Erdem M; Ataoglu O; Guner H
    Int J Gynecol Cancer; 2006; 16(5):1789-93. PubMed ID: 17009973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different synovial vasculogenic profiles of primary, rapidly destructive and osteonecrosis-induced hip osteoarthritis. An immunohistochemistry study.
    Gurzu S; Turdean SG; Pop ST; Zazgyva A; Roman CO; Opris M; Jung I
    Int Orthop; 2017 Jun; 41(6):1107-1112. PubMed ID: 27704157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD105- and CD31-assessed microvessel density in laryngeal carcinoma biopsies as a predictor of recurrence after exclusive primary surgery.
    Franz L; Alessandrini L; Saccardo T; Frigo AC; Marioni G
    Ann Diagn Pathol; 2020 Oct; 48():151608. PubMed ID: 32890907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study.
    Rubatt JM; Darcy KM; Hutson A; Bean SM; Havrilesky LJ; Grace LA; Berchuck A; Secord AA
    Gynecol Oncol; 2009 Mar; 112(3):469-74. PubMed ID: 19135712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.